We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10.52%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$15.6B
AUM Growth
+$1.35B
(+9.5%)
Cap. Flow
+$272M
Cap. Flow
% of AUM
1.74%
Top 10 Holdings %
Top 10 Hldgs %
17.46%
Holding
2,121
New
637
Increased
418
Reduced
436
Closed
588
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$208M |
| 2 |
Charles River Laboratories
CRL
|
+$150M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$91.1M |
| 4 |
Keurig Dr Pepper
KDP
|
+$83.8M |
| 5 |
Medtronic
MDT
|
+$83.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$170M |
| 2 |
Boston Scientific
BSX
|
+$145M |
| 3 |
Procter & Gamble
PG
|
+$139M |
| 4 |
EPAM Systems
EPAM
|
+$101M |
| 5 |
Fidelity National Information Services
FIS
|
+$76.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.06% |
| 2 | Consumer Discretionary | 14.39% |
| 3 | Financials | 10.11% |
| 4 | Technology | 9.6% |
| 5 | Industrials | 7.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.58B
| $343K | ﹤0.01% |
+4,451
| New | +$339K |
|
1327
First Bancorp
FBNC
$2.65B
| $343K | ﹤0.01% |
+16,386
| New | +$351K |
|
|
TBCH
1328
Turtle Beach Corp
TBCH
$257M
| $341K | ﹤0.01% |
18,709
-160,153
| -90% | -$2.87M |
|
1329
Luxfer Holdings
LXFR
$457M
| $339K | ﹤0.01% |
+27,044
| New | +$368K |
|
1330
Loews
L
$24.6B
| $338K | ﹤0.01% |
9,735
-33,134
| -77% | -$1.19M |
|
1331
nCino
NCNO
$2.05B
| $338K | ﹤0.01% |
+4,248
| New | +$339K |
|
|
FL
1332
DELISTED
Foot Locker
FL
| $337K | ﹤0.01% |
+10,194
| New | +$311K |
|
1333
Frontdoor
FTDR
$5.21B
| $337K | ﹤0.01% |
+8,672
| New | +$370K |
|
1334
GDS Holdings
GDS
$6.09B
| $336K | ﹤0.01% |
4,108
-4,075
| -50% | -$326K |
|
1335
Ares Capital
ARCC
$13.7B
| $334K | ﹤0.01% |
+23,931
| New | +$340K |
|
1336
Criteo
CRTO
$1.07B
| $334K | ﹤0.01% |
27,385
-130,138
| -83% | -$1.68M |
|
1337
Transmedics
TMDX
$2.6B
| $334K | ﹤0.01% |
24,252
+9,354
| +63% | +$160K |
|
1338
Expro Ltd
XPRO
$1.79B
| $332K | ﹤0.01% |
35,875
-1,874
| -5% | -$25.2K |
|
1339
Beazer Homes USA
BZH
$914M
| $331K | ﹤0.01% |
25,098
-18,498
| -42% | -$216K |
|
1340
Arcturus Therapeutics
ARCT
$162M
| $330K | ﹤0.01% |
+7,689
| New | +$382K |
|
|
BBU
1341
DELISTED
Brookfield Business Partners
BBU
| $330K | ﹤0.01% |
+16,973
| New | +$332K |
|
1342
Mistras Group
MG
$489M
| $328K | ﹤0.01% |
83,994
-9,843
| -10% | -$39.5K |
|
1343
Dine Brands
DIN
$455M
| $326K | ﹤0.01% |
+5,975
| New | +$302K |
|
|
INZY
1344
DELISTED
Inozyme Pharma
INZY
| $326K | ﹤0.01% |
+12,418
| New | +$308K |
|
1345
UNIFI
UFI
$123M
| $326K | ﹤0.01% |
25,411
+1,645
| +7% | +$20.5K |
|
|
PXD
1346
DELISTED
Pioneer Natural Resource Co.
PXD
| $326K | ﹤0.01% |
+3,791
| New | +$373K |
|
1347
Grand Canyon Education
LOPE
$4B
| $325K | ﹤0.01% |
+4,060
| New | +$368K |
|
|
CLDR
1348
DELISTED
Cloudera, Inc.
CLDR
| $325K | ﹤0.01% |
+29,852
| New | +$346K |
|
|
ABB
1349
DELISTED
ABB Ltd
ABB
| $323K | ﹤0.01% |
+12,677
| New | +$324K |
|
1350
Expedia Group
EXPE
$35.2B
| $322K | ﹤0.01% |
3,515
-8,428
| -71% | -$758K |
|
Similar funds
Marshall Wace's Q3 2020 Portfolio in Review
As of Q3 2020, Marshall Wace held 2,121 positions worth $15.6B, up 9.5% from $14.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q3 2020 filing shows 637 new, 418 increased, 436 reduced and 588 closed positions. Its largest new stake was Keurig Dr Pepper: 2,859,399 shares worth $78.9M. The largest sale was Alibaba, an estimated $170M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- Marshall Wace's largest Q3 2020 buy was Keurig Dr Pepper: 2,859,399 shares worth $78.9M.
- Marshall Wace added most to Alphabet (Google) Class A in Q3 2020, an estimated $208M increase.
- Marshall Wace's biggest Q3 2020 reduction was Alibaba, cutting an estimated $170M.
- Marshall Wace fully exited Procter & Gamble in Q3 2020, selling an estimated $139M.
- Marshall Wace's ten largest holdings make up 17% of its $15.6B portfolio in Q3 2020.
- Marshall Wace opened 637 new positions and closed 588 in Q3 2020.
- Marshall Wace's portfolio value rose 9.5% quarter-over-quarter to $15.6B.
Based on Marshall Wace's 13F filing for Q3 2020, filed 16 Nov 2020.